You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Healthy male subjects

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Male Subjects Trial (Recombinant Humanized Anti-PD-1 Monoclonal Antibody Solution for Injection, Pembrolizumab

Not yet recruiting
  • Healthy Male Subjects
  • Recombinant Humanized Anti-PD-1 Monoclonal Antibody Solution for Injection
  • Pembrolizumab injection
  • (no location specified)
Oct 30, 2023

Healthy Male Subjects Trial in Shanghai ([14C] Yiqibuvir)

Not yet recruiting
  • Healthy Male Subjects
  • [14C] Yiqibuvir
  • Shanghai, Shanghai, China
    Shanghai xuhui central hospital
Aug 16, 2023

Healthy Male Subjects Trial in Brooklyn (Savolitinib, Fluvoxamine)

Not yet recruiting
  • Healthy Male Subjects
  • Brooklyn, Maryland
    Research Site
May 25, 2023

Healthy Trial in Kalamazoo (CORT125134)

Completed
  • Healthy
  • Kalamazoo, Michigan
    Jasper Clinic
Oct 17, 2023

Psoriasis Trial (BR201, Cosentyx(Secukinumab ))

Not yet recruiting
  • Psoriasis
  • BR201
  • Cosentyx（Secukinumab ）
  • (no location specified)
Nov 6, 2023

Healthy Male Trial in Beijing (Envafolimab with new manufacturing process, Envafolimab with old manufacturing process)

Not yet recruiting
  • Healthy Male
  • Envafolimab with new manufacturing process
  • Envafolimab with old manufacturing process
  • Beijing, Beijing, China
    Beijing Gaobo Boren Hosipital
May 9, 2023

Healthy Male Subjects Trial in Lincoln (14C RPT193)

Not yet recruiting
  • Healthy Male Subjects
  • 14C RPT193
  • Lincoln, Nebraska
    Celerion
Oct 13, 2023

Healthy Male Subjects Trial in Christchurch (Denosumab)

Recruiting
  • Healthy Male Subjects
  • Denosumab
  • Christchurch, Christchuch, New Zealand
    NZCR: New Zealand Clinical Research
Jan 24, 2023

Healthy Male Subjects Trial in Shanghai ([14C] Antaitavir Hasophate)

Completed
  • Healthy Male Subjects
  • [14C] Antaitavir Hasophate
  • Shanghai, Shanghai, China
    Shanghai xuhui central hospital
Jan 4, 2023

This is a Phase Study Conducted in Healthy Volunteers, Osteoporosis Trial (Denosumab)

Not yet recruiting
  • This is a Phase Study Conducted in Healthy Volunteers
  • Osteoporosis
  • Denosumab
  • (no location specified)
May 17, 2023

Healthy Male Subjects Trial (Savolitinib, Digoxin, Metformin Hydrochloride)

Not yet recruiting
  • Healthy Male Subjects
  • (no location specified)
Mar 3, 2023

Healthy Trial in Madison (Fadraciclib)

Active, not recruiting
  • Healthy
  • Madison, Wisconsin
    Labcorp Clinical Research Unit
Apr 5, 2023

Hypertriglyceridemia Trial in Hellerup (DHA-NAT, Placebo)

Recruiting
  • Hypertriglyceridemia
  • DHA-NAT
  • Placebo
  • Hellerup, Denmark
    Center for Clinical Metabolic Research, Herlev-Gentofte Hospital
Jul 11, 2023

Immune System Disorder (Healthy Volunteer) Trial in Baltimore (Belumosudil mesylate, Placebo)

Completed
  • Immune System Disorder (Healthy Volunteer)
  • Belumosudil mesylate
  • Placebo
  • Baltimore, Maryland
    Investigational site
Jun 15, 2023

Healthy Trial in Tel Aviv (Anti-human CCL24 mAb (CM-101), Placebo)

Completed
  • Healthy
  • Anti-human CCL24 monoclonal antibody (CM-101)
  • Placebo
  • Tel Aviv, Israel
    Tel Aviv Sourasky Medical Center
Sep 7, 2023

Healthy Subject Trial in Seongnam, Daejeon (CT-P41, US-licensed Prolia)

Completed
  • Healthy Subject
  • CT-P41
  • US-licensed Prolia
  • Seongnam, Bundang-gu, Korea, Republic of
  • +1 more
Sep 7, 2023

Hemophilia A, Hemophilia B, Blood Coagulation Disorders Trial in Seoul (TU7710, Normal saline)

Recruiting
  • Hemophilia A
  • +2 more
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Sep 8, 2023

Healthy Volunteer Trial (ABBV-903)

Not yet recruiting
  • Healthy Volunteer
  • (no location specified)
Aug 10, 2023

NASH With Fibrosis Trial ([14C]-rencofilstat 225mg)

Not yet recruiting
  • NASH With Fibrosis
  • [14C]-rencofilstat 225mg
  • (no location specified)
Feb 21, 2023

Healthy Trial in Seoul (CKR-051 Dose 1, CKR-051 Dose 2, CKR-051 Dose 3)

Not yet recruiting
  • Healthy
  • CKR-051 Dose 1
  • +4 more
  • (no location specified)
Apr 18, 2023

Healthy Trial in Berlin, Hamburg (LY06006 (Denosumab Biosimilar), US-Prolia (Denosumab), EU-Prolia)

Completed
  • Healthy
  • LY06006 (Denosumab Biosimilar)
  • +2 more
  • Berlin, Germany
  • +1 more
Oct 18, 2023

Nonalcoholic Steatohepatitis (NASH), Primary Sclerosing Cholangitis (PSC), Systemic Sclerosis (SSc) Trial in Tel Aviv (CM-101,

Completed
  • Nonalcoholic Steatohepatitis (NASH)
  • +2 more
  • Tel Aviv, Israel
    Tel Aviv Sourasky Medical Center
Sep 7, 2023

Healthy Trial (BI 1584862, Placebo)

Not yet recruiting
  • Healthy
  • BI 1584862
  • Placebo
  • (no location specified)
Dec 1, 2023

Fungal Disease Trial in Nottingham (Ibrexafungerp)

Recruiting
  • Fungal Disease
  • Nottingham, United Kingdom
    Quotient Sciences Limited
Dec 20, 2022

Healthy Volunteers Trial in Lincoln ([14C]-TVB-2640)

Completed
  • Healthy Volunteers
  • Lincoln, Nebraska
    Celerion Inc.
Dec 23, 2022